Polymorphous Adenocarcinoma (PAC), formerly referred to as Polymorphous Low-Grade Adenocarcinoma (PLGA), is a very rare form of salivary gland cancer that primarily occurs in minor salivary glands, such as those in the palate. This is normally a very slow-growing cancer of low grade that usually has an excellent prognosis if it is diagnosed early enough and receives appropriate treatment. PAC is unlikely to spread to distant sites in the body; however, it may recur locally if not totally excised.
Polymorphous Adenocarcinoma (PAC) is a cancerous tumor that arises from epithelial cells of salivary glands. "Polymorphous" describes a tumor with different microscopic growth patterns despite consisting of uniform tumor cells.
According to the World Health Organization (WHO), Polymorphous Adenocarcinoma (PAC) is now referred to as Polymorphous Low-Grade Adenocarcinoma.
PAC is classified as low-grade cancer due to the fact that it is generally slow-growing.
Most of the time, Polymorphous Adenocarcinoma occurs in the minor salivary glands.
Some of the locations where they can occur are as follows:
This rarely affects the major salivary glands, such as the parotid or submandibular glands.
The precise causes of PAC remain unclear.
Studies have found that some genetic changes are involved, including mutations in the PRKD gene family, mainly the PRKD1 gene, in most patients.
In most cases, no environmental or genetic factor is found for this cancer.
Smoking and alcohol, which cause other head and neck cancers, have not been related to this cancer till now.
People with higher chances of Polymorphous Adenocarcinoma include:
Children are not usually affected by PAC.
Because PAC is a slowly developing disease, symptoms usually develop slowly over months or even years.
Typical symptoms include:
Most of the patients have no pain before the mass increases in size.
Polymorphous adenocarcinoma develops slowly as a rule.
The following features should be considered:
Sometimes the disease may recur locally, but it can be prevented by complete surgery.
Diagnosis is performed using clinical examination and special investigations.
A head and Neck Surgeon or ENT Specialist examines:
The MRI scan is very helpful in assessing soft-tissue and nerve involvement.
A biopsy in the form of an incisional/core biopsy is often done prior to definitive therapy to confirm the diagnosis.
The tumor will then be examined for:
It all depends on the location, size, and extent of the tumor.
The first and most successful treatment modality is surgery.
Surgery aims at removing the tumor completely with adequate margins and preservation of normal oral functions when feasible.
In some locations, surgery may involve:
Prophylactic removal of neck lymph nodes is not done routinely due to the rare metastasis to lymph nodes.
Neck dissection is done when enlarged or suspect lymph nodes are found.
Radiotherapy could be recommended in cases where:
Chemotherapy is not usually needed in most cases and is only used in advanced or metastatic cases.
Yes; however, metastasis is relatively rare.
Potential sites of spread include:
The majority of patients have localized tumors that can be successfully managed through surgery.
The prognosis is generally good.
Prognostic factors include:
The great majority of patients do very well, with most patients being cured through surgery alone.
Follow-up appointments remain very important, as recurrence can occur years later.
Follow-up is done through:
Any oral swelling needs to be reported.
Yes. Patients are usually successfully treated by surgery, especially in the early stages of the disease.
No. PAC is described as a low-grade, slowly growing tumor of salivary gland origin with a good prognosis.
Yes. Recurrence is rare in patients undergoing complete surgery; nevertheless, long-term follow-up is advised.
No. Only patients presenting with high-risk factors such as positive margins, recurrences, or wide perineural invasion require radiotherapy.
Yes, although lymph node metastasis is less common than in many other salivary gland cancers.
As PAC is a slow-growing tumor, recurrence is possible several years after treatment. Follow-up ensures the timely diagnosis of recurrence.
Polymorphous Adenocarcinoma cannot be prevented. Nevertheless, any swelling, mass, or ulcer on the mucosa, especially of the palate, that does not heal within 2 weeks should be examined by a specialist. Early diagnosis and treatment ensure the best chances of cure.
Tender Palm Super-Speciality Hospital offers advanced Polymorphous Adenocarcinoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced head and neck surgeons and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including surgical resection, radiation therapy, and comprehensive oncological management. Our Head and Neck Surgery and Oncology team has decades of experience in successfully treating Polymorphous Adenocarcinoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com